We are monitoring the impact of COVID-19 on Renal Disease Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1217
Share on
Share on

Global Renal Disease Therapeutics Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Application, Treatment Devices, and Region – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1217
Pages: 175

Renal Disease Therapeutics Market Size (2021 to 2026)

The global renal disease therapeutics market size is predicted to grow at an impressive CAGR between 2021 to 2026. Renal diseases are a progressive loss of the proper functioning of the kidneys. Over a more extended period, the associated renal system fuels the market because of its high incidence rate worldwide.

The kidneys have many life-sustaining functions, such as cleansing the blood by filtering waste products and excess fluid, regulating blood pressure, and maintaining the balance of salt and minerals. When kidney failure occurs, they ultimately lose their vital function, which is fatal. Kidney damage/failure can be developed acutely (AKI) and over time (CKD). Three types of treatment are most prevalent to cure kidney failure: prescription medications, surgical intervention, dialysis (peritoneal dialysis, hemodialysis, and continuous renal replacement therapy), which are frequently used in combination to treat a single case of renal failure.

Some of the key drivers of the Renal Disease Therapeutics Market are increasing aging population, growing awareness of both acute and chronic kidney disease, an increasing number of individuals with insurance due to the Affordable Care Act, Increasing Diabetic Population, and rising demand for advanced diagnostics and therapeutics for the disease.

Disparities of Renal Transplant Therapy, expiring of patents of some of the branded drugs for the late-stage CKD, and changing reimbursement scenarios in some significant countries, Negative Societal Effects are the restraints that hinder the growth of the market.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Application Mode, Treatment and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Amgen Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Hoffmann-La Roche Inc., Shire Inc., Fresenius Medical Care, Baxter International and Davita Healthcare Partners

 

This research report on the global renal disease therapeutics market has been segmented and sub-segmented based on application mode, treatment, and region.

Renal Disease Therapeutics Market - By Application Mode:

  • Kidney Stone Disease
  • End-Stage Kidney Disease
  • Kidney Failure
  • Chronic Kidney Disease
  • Hypertension
  • Diabetes
  • Anemia

Renal Disease Therapeutics Market - By Treatment:

  • Dialysis Equipment
  • Renal Denervation Devices
  • Wearable Artificial Kidney Device
  • Distal Embolic Protection Devices

Renal Disease Therapeutics Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American market is predicted to dominate the global renal disease therapeutics market during the forecast period. Europe comes next. However, the Asia-Pacific is projected to show the highest CAGR over the forecast period due to an increasing number of high blood pressure and diabetic patients and a growing demand for advanced diagnostics and therapeutics in the region.

KEY MARKET PLAYERS:

Companies leading the global renal disease therapeutics market profiled in the report are Amgen Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Hoffmann-La Roche Inc., Shire Inc., Fresenius Medical Care, Baxter International, and Davita Healthcare Partners.

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 Epidemology             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 Application 

                                5.1.1 Introduction

                                5.1.2 Kidney Stone Disease

                                5.1.3 End-Stage Kidney Disease

                                5.1.4 Kidney Failure

                                5.1.5 Chronic Kidney Disease

                                5.1.6 Hypertension

                                5.1.7 Diabetes

                                5.1.8 Anaemia

                                5.1.4 Y-o-Y Growth Analysis, By Application

                                5.1.5 Market Attractiveness Analysis, By Application

                                5.1.6 Market Share Analysis, By Application

                5.2 Treatment devices  

                                5.2.1 Introduction

                                5.2.2 Dialysis Equipment

                                5.2.3 Renal Denervation devices

                                5.2.4 Wearable artificial kidney device

                                5.2.5 distal embolic protection devices

                                5.2.6 Y-o-Y Growth Analysis, By Treatment devices

                                5.2.7 Market Attractiveness Analysis, By Treatment devices

                                5.2.8 Market Share Analysis, By Treatment devices

6. Geographical Analysis                              

                6.1 Introduction              

                                6.1.1 Regional Trends

                                6.1.2 Impact Analysis

                                6.1.3 Y-o-Y Growth Analysis

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Treatment Devices

                                6.1.4 Market Attractiveness Analysis

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Treatment devices

                                6.1.5 Market Share Analysis

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Treatmentr Devices  

                6.2 North America          

                                6.1.1 Introduction

                                6.1.2 United States

                                6.1.3 Canada 

                6.3 Europe         

                                6.2.1 Introduction

                                6.2.2 U.K

                                6.2.3 Spain

                                6.2.4 Germany

                                6.2.5 Italy 

                                6.2.6 France

                6.4 Asia-Pacific 

                                6.3.1 Introduction

                                6.3.2 China 

                                6.3.3 India 

                                6.3.4 Japan 

                                6.3.5 Australia

                                6.3.6 South Korea

                6.5 Latin America            

                                6.4.1 Introduction

                                6.4.2 Brazil

                                6.4.3 Argentina

                                6.4.4 Mexico

                                6.4.5 Rest of Latin America

                6.6 Middle East & Africa

                                6.5.1 Introduction

                                6.5.2 Middle-East

                                6.5.3 Africa

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Amgen Inc. 

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments

                                8.1.5 SWOT analysis

                                8.1.6 Analyst View

                8.2 Merck & Co., Inc.     

                8.3 Bristol-Myers Squibb Company          

                8.4 Hoffmann-La Roche Inc         

                8.5 Shire Inc.     

                8.6 Fresenius Medical Care         

                8.7 Baxter International

                8.8 Davita Healthcare Partners  

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Market Outlook and Investment Opportunities                           

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Renal Disease Therapeutics Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  3. Global Kidney Stone Disease Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global End-Stage Kidney Disease Market, By Region, From 2021 to 2026 (USD Billion)
  5. Global Kidney Failure Market, By Region, From 2021 to 2026 (USD Billion)
  6. Global Chronic Kidney Disease Market, By Region, From 2021 to 2026 (USD Billion)
  7. Global Hypertension Market, By Region, From 2021 to 2026 (USD Billion)
  8. Global Diabetes Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Anemia Market, By Region, From 2021 to 2026 (USD Billion)
  10. Global Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  11. Global Dialysis Equipment Market, By Region, From 2021 to 2026 (USD Billion)
  12. Global Renal Denervation Devices Market, By Region, From 2021 to 2026 (USD Billion)
  13. Global Wearable Artificial Kidney Device Market, By Region, From 2021 to 2026 (USD Billion)
  14. Global Distal Embolic Protection Devices Market, By Region, From 2021 to 2026 (USD Billion)
  15. North America Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  16. North America Kidney Stone Disease Market, By Region, From 2021 to 2026 (USD Billion)
  17. North America End-Stage Kidney Disease Market, By Region, From 2021 to 2026 (USD Billion)
  18. North America Kidney Failure Market, By Region, From 2021 to 2026 (USD Billion)
  19. North America Chronic Kidney Disease Market, By Region, From 2021 to 2026 (USD Billion)
  20. North America Hypertension Market, By Region, From 2021 to 2026 (USD Billion)
  21. North America Diabetes Market, By Region, From 2021 to 2026 (USD Billion)
  22. North America Anemia Market, By Region, From 2021 to 2026 (USD Billion)
  23. North America Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  24. North America Dialysis Equipment Market, By Region, From 2021 to 2026 (USD Billion)
  25. North America Renal Denervation Devices Market, By Region, From 2021 to 2026 (USD Billion)
  26. North America Wearable Artificial Kidney Device Market, By Region, From 2021 to 2026 (USD Billion)
  27. North America Distal Embolic Protection Devices Market, By Region, From 2021 to 2026 (USD Billion)
  28. United States Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  29. United States Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  30. Canada Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  31. Canada Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  32. Europe Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  33. Europe Kidney Stone Disease Market, By Region, From 2021 to 2026 (USD Billion)
  34. Europe End-Stage Kidney Disease Market, By Region, From 2021 to 2026 (USD Billion)
  35. Europe Kidney Failure Market, By Region, From 2021 to 2026 (USD Billion)
  36. Europe Chronic Kidney Disease Market, By Region, From 2021 to 2026 (USD Billion)
  37. Europe Hypertension Market, By Region, From 2021 to 2026 (USD Billion)
  38. Europe Diabetes Market, By Region, From 2021 to 2026 (USD Billion)
  39. Europe Anemia Market, By Region, From 2021 to 2026 (USD Billion)
  40. Europe Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  41. Europe Dialysis Equipment Market, By Region, From 2021 to 2026 (USD Billion)
  42. Europe Renal Denervation Devices Market, By Region, From 2021 to 2026 (USD Billion)
  43. Europe Wearable Artificial Kidney Device Market, By Region, From 2021 to 2026 (USD Billion)
  44. Europe Distal Embolic Protection Devices Market, By Region, From 2021 to 2026 (USD Billion)
  45. U.K. Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  46. U.K. Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  47. Germany Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  48. Germany Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  49. France Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  50. France Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  51. Italy Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  52. Italy Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  53. Spain Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  54. Spain Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  55. Asia Pacific Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  56. Asia Pacific Kidney Stone Disease Market, By Region, From 2021 to 2026 (USD Billion)
  57. Asia Pacific End-Stage Kidney Disease Market, By Region, From 2021 to 2026 (USD Billion)
  58. Asia Pacific Kidney Failure Market, By Region, From 2021 to 2026 (USD Billion)
  59. Asia Pacific Chronic Kidney Disease Market, By Region, From 2021 to 2026 (USD Billion)
  60. Asia Pacific Hypertension Market, By Region, From 2021 to 2026 (USD Billion)
  61. Asia Pacific Diabetes Market, By Region, From 2021 to 2026 (USD Billion)
  62. Asia Pacific Anemia Market, By Region, From 2021 to 2026 (USD Billion)
  63. Asia Pacific Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  64. Asia Pacific Dialysis Equipment Market, By Region, From 2021 to 2026 (USD Billion)
  65. Asia Pacific Renal Denervation Devices Market, By Region, From 2021 to 2026 (USD Billion)
  66. Asia Pacific Wearable Artificial Kidney Device Market, By Region, From 2021 to 2026 (USD Billion)
  67. Asia Pacific Distal Embolic Protection Devices Market, By Region, From 2021 to 2026 (USD Billion)
  68. Japan Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  69. Japan Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  70. China Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  71. China Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  72. India Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  73. India Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  74. Australia Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  75. Australia Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  76. South Korea Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  77. South Korea Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  78. Latin America Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  79. Latin America Kidney Stone Disease Market, By Region, From 2021 to 2026 (USD Billion)
  80. Latin America End-Stage Kidney Disease Market, By Region, From 2021 to 2026 (USD Billion)
  81. Latin America Kidney Failure Market, By Region, From 2021 to 2026 (USD Billion)
  82. Latin America Chronic Kidney Disease Market, By Region, From 2021 to 2026 (USD Billion)
  83. Latin America Hypertension Market, By Region, From 2021 to 2026 (USD Billion)
  84. Latin America Diabetes Market, By Region, From 2021 to 2026 (USD Billion)
  85. Latin America Anemia Market, By Region, From 2021 to 2026 (USD Billion)
  86. Latin America Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  87. Latin America Dialysis Equipment Market, By Region, From 2021 to 2026 (USD Billion)
  88. Latin America Renal Denervation Devices Market, By Region, From 2021 to 2026 (USD Billion)
  89. Latin America Wearable Artificial Kidney Device Market, By Region, From 2021 to 2026 (USD Billion)
  90. Latin America Distal Embolic Protection Devices Market, By Region, From 2021 to 2026 (USD Billion)
  91. Brazil Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  92. Brazil Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  93. Argentina Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  94. Argentina Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  95. Mexico Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  96. Mexico Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  97. Rest of Latin America Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  98. Rest of Latin America Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  99. Middle East and Africa Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  100. Middle East and Africa Kidney Stone Disease Market, By Region, From 2021 to 2026 (USD Billion)
  101. Middle East and Africa End-Stage Kidney Disease Market, By Region, From 2021 to 2026 (USD Billion)
  102. Middle East and Africa Kidney Failure Market, By Region, From 2021 to 2026 (USD Billion)
  103. Middle East and Africa Chronic Kidney Disease Market, By Region, From 2021 to 2026 (USD Billion)
  104. Middle East and Africa Hypertension Market, By Region, From 2021 to 2026 (USD Billion)
  105. Middle East and Africa Diabetes Market, By Region, From 2021 to 2026 (USD Billion)
  106. Middle East and Africa Anemia Market, By Region, From 2021 to 2026 (USD Billion)
  107. Middle East and Africa Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  108. Middle East and Africa Dialysis Equipment Market, By Region, From 2021 to 2026 (USD Billion)
  109. Middle East and Africa Renal Denervation Devices Market, By Region, From 2021 to 2026 (USD Billion)
  110. Middle East and Africa Wearable Artificial Kidney Device Market, By Region, From 2021 to 2026 (USD Billion)
  111. Middle East and Africa Distal Embolic Protection Devices Market, By Region, From 2021 to 2026 (USD Billion)
  112. Middle East Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  113. Middle East Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  114. Africa Renal Disease Therapeutics Market, By Application Mode, From 2021 to 2026 (USD Billion)
  115. Africa Renal Disease Therapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample